RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16954505http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16954505http://www.w3.org/2000/01/rdf-schema#comment"Genes that are strongly repressed after B-cell activation are candidates for being inactivated, mutated, or repressed in B-cell malignancies. Krüppel-like factor 4 (Klf4), a gene down-regulated in activated murine B cells, is expressed at low levels in several types of human B-cell lineage lymphomas and leukemias. The human KLF4 gene has been identified as a tumor suppressor gene in colon and gastric cancer; in concordance with this, overexpression of KLF4 can suppress proliferation in several epithelial cell types. Here we investigate the effects of KLF4 on pro/pre-B-cell transformation by v-Abl and BCR-ABL, oncogenes that cause leukemia in mice and humans. We show that overexpression of KLF4 induces arrest and apoptosis in the G1 phase of the cell cycle. KLF4-mediated death, but not cell-cycle arrest, can be rescued by Bcl-XL overexpression. Transformed pro/pre-B cells expressing KLF4 display increased expression of p21CIP and decreased expression of c-Myc and cyclin D2. Tetracycline-inducible expression of KLF4 in B-cell progenitors of transgenic mice blocks transformation by BCR-ABL and depletes leukemic pre-B cells in vivo. Collectively, our work identifies KLF4 as a putative tumor suppressor in B-cell malignancies."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.org/dc/terms/identifier"doi:10.1182/blood-2006-03-011106"xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Yang V.W."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Huettner C.S."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Segre J.A."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Fruman D.A."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Kharas M.G."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Yusuf I."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/author"Scarfone V.M."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/pages"747-755"xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/title"KLF4 suppresses transformation of pre-B cells by ABL oncogenes."xsd:string
http://purl.uniprot.org/citations/16954505http://purl.uniprot.org/core/volume"109"xsd:string
http://purl.uniprot.org/citations/16954505http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16954505
http://purl.uniprot.org/citations/16954505http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16954505
http://purl.uniprot.org/uniprot/#_B7ZCH1-mappedCitation-16954505http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16954505
http://purl.uniprot.org/uniprot/#_B7ZCH2-mappedCitation-16954505http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16954505
http://purl.uniprot.org/uniprot/#_Q60793-mappedCitation-16954505http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16954505
http://purl.uniprot.org/uniprot/Q60793http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16954505
http://purl.uniprot.org/uniprot/B7ZCH2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16954505
http://purl.uniprot.org/uniprot/B7ZCH1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/16954505